Theory is first and evidence-based is king! Academician Zhang Boli: Let academic theoretical innovation stimulate the development potential and vitality of traditional Chinese medicine – Health Home – Northern Network

On February 24, the 20th International Congress of Collateral Medicine was held in Shijiazhuang City. The picture shows the meeting scene.Photo by Li Xiaodong

Hebei Daily Client News (Sun Yang, Li Xiaodong) On February 24, the 20th International Congress of Collateral Diseases was held in Shijiazhuang City. Zhang Boli, an academician of the Chinese Academy of Engineering, emphasized that only by strengthening the innovative development of academic theories of traditional Chinese medicine and fully stimulating the potential and vitality of the development of traditional Chinese medicine can traditional Chinese medicine be promoted to stand in the world of science.

“Currently, the development of traditional Chinese medicine is in a period of important strategic opportunities with great potential and great achievements.” Academician Zhang Boli said that the theory of collateral disease, as a model for the inheritance and innovation of traditional Chinese medicine, has been developed in the network with the joint efforts of domestic and foreign experts represented by Academician Wu Yiling. Fruitful results have been achieved in inheriting and innovating disease theories, improving clinical efficacy, and developing innovative drugs. We have also summarized the successful experience of ‘theory first, evidence-based is king’, which has effectively promoted the construction of a scientific and technological innovation system of traditional Chinese medicine and the cause of traditional Chinese medicine. develop.

Academician Zhang Boli emphasized that “theory first” refers to the inheritance and innovation of the theory of collateral disease. “Collateral disease” was found in the “Huangdi Neijing”. Later, Ye Tianshi proposed some treatment principles and methods of the theory of collateral disease. It was Academician Wu Yiling who truly integrated the theory of collateral disease into clinical practice and systematically proposed the essence, treatment mechanism, evidence-based evidence, and drug development of collateral disease. Therefore, what Academician Wu Yiling did is the fourth milestone in theoretical research on collateral disease. “Evidence-based is king.” Traditional Chinese medicine has a history of 5,000 years. The efficacy of traditional Chinese medicine is certain, but modern evidence is needed. Academician Wu Yiling’s team drew on new methods of modern medical scientific research to carry out a series of evidence-based studies and achieved results. Important results.

On February 24, the 20th International Congress of Collateral Medicine was held in Shijiazhuang City. The picture shows Academician Zhang Boli.Photo by Li Xiaodong

Academician Zhang Boli believes that these studies have promoted the construction of the scientific and technological innovation system of traditional Chinese medicine and the development of traditional Chinese medicine. The choroid theory, a branch of the collateral disease discipline, has guided the research on the prevention and treatment of microvascular lesions and made significant progress, winning the first prize of the 2019 National Science and Technology Progress Award. Award, and was selected as the landmark scientific and technological achievements of traditional Chinese medicine in the new era of the China Society of Traditional Chinese Medicine (2012-2022). Tongluo drugs have achieved outstanding results in intervening in the cardiovascular event chain. In particular, the addition of Tongxinluo to standardized treatment has achieved good results in the treatment of acute myocardial infarction. The relevant results were published in “JAMA”, one of the four top medical journals in the world. This major publication fully demonstrates the exact efficacy of collateral disease theory in the treatment of cardiovascular and cerebrovascular diseases, and has been recognized by the world.

At the same time, the collateral disease theory has a new branch – the Qi collateral theory, which has formed a theory to guide the prevention and treatment of neurological, endocrine, immune and other system diseases. Focusing on anti-aging research, we applied the theory of Qi and Luo and the theory of essence, qi, and spirit to guide anti-aging research, and developed Bazi Bushen Capsule, which achieved clear anti-aging effects. It is believed that anti-aging research guided by the theory of Qiluo, Jingqi and Shen will achieve outstanding results on the basis of being approved as a national key research and development plan.